Lantheus Holdings (LNTH) EBIT Margin Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) EBIT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | -1,277.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,277.00 |
| Mar 31, 2026 | 2,466.00 |
| Dec 31, 2025 | 8,421.00 |
| Sep 30, 2025 | -2,447.00 |
| Jun 30, 2025 | -498.00 |
| Mar 31, 2025 | -83.00 |
| Dec 31, 2024 | 5,639.00 |
| Sep 30, 2024 | 4,935.00 |
| Jun 30, 2024 | 5,257.00 |
| Mar 31, 2024 | 1,194.00 |
| Dec 31, 2023 | 91,713.00 |
| Sep 30, 2023 | 4,105.00 |
| Jun 30, 2023 | 4,699.00 |
| Mar 31, 2023 | -1,096.00 |
| Dec 31, 2022 | -7,916.00 |
| Sep 30, 2022 | 2,590.00 |
| Jun 30, 2022 | 1,129.00 |
| Mar 31, 2022 | 952.00 |
| Dec 31, 2021 | -4,691.00 |
| Sep 30, 2021 | -3,258.00 |